UPDATE: Jefferies Starts Vaccitech (VACC) at Buy, 'Primed Vaccine Pipeline Ready to Boost the Stock'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
William Blair Starts Vaccitech (VACC) at Outperform
May 25, 2021 4:35 AM EDTWilliam Blair analyst Andy T. Hsieh initiates coverage on Vaccitech (NASDAQ: VACC) with a Outperform rating.
For an analyst ratings summary and ratings history on Vaccitech click here. For more ratings news on Vaccitech click here.
Shares of Vaccitech closed at $14.32 yesterday.
... MoreUPDATE: Morgan Stanley Starts Vaccitech (VACC) at Overweight
May 25, 2021 2:09 AM EDT(Updated - May 25, 2021 4:41 AM EDT)
Morgan Stanley analyst Matthew Harrison initiates coverage on Vaccitech (NASDAQ: VACC) with a Overweight rating and a price target of $22.00.
The analyst comments "Vaccitech is leveraging its robust T-cell platform to target major viral antigens... More
UPDATE: H.C. Wainwright Starts Vaccitech (VACC) at Buy
May 24, 2021 6:22 AM EDT(Updated - May 24, 2021 6:39 AM EDT)
H.C. Wainwright analyst Yi Chen initiates coverage on Vaccitech (NASDAQ: VACC) with a Buy rating and a price target of $25.00.
The analyst comments "Vaccitech is a clinical-stage biopharmaceutical company, which was founded in 2016 as a spin-out from the Jenner Institute at the University of Oxford. The companys technology platform is a heterologous primeboost approach that... More
